Mirae Asset Global ETFs Holdings’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Buy
+28,800
New +$109K ﹤0.01% 2680
2025
Q2
– Sell
-36,539
Closed -$46.4K – 3149
2025
Q1
$46.4K Buy
36,539
+1,560
+4% +$4.08K ﹤0.01% 2864
2024
Q4
$114K Buy
34,979
+726
+2% +$2.62K ﹤0.01% 2654
2024
Q3
$113K Buy
34,253
+3,340
+11% +$13K ﹤0.01% 2661
2024
Q2
$131K Buy
+30,913
New +$301K ﹤0.01% 2454

Other funds holding MGNX

Mirae Asset Global ETFs Holdings's MGNX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in MacroGenics (MGNX) in Q2 2026: 28,800 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #2680 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in MGNX as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in MGNX in Q2 2024 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 28,800 shares of MacroGenics worth $133K as of Q2 2026.
  • MacroGenics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • MacroGenics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2680 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in MacroGenics in Q2 2024 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.